The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Biotechnology

Background:

• Cholesterol accumulation in pro-inflammatory endothelial cells (EC) is implicated in atherogenesis.
• MicroRNA-33a-5p (miR-33a-5p) is a potential therapeutic target for atherosclerosis.
• Upregulating ABCA1 enhances cholesterol efflux, a key factor in preventing atherosclerosis.

Purpose of the Study:

• To investigate if inhibiting miR-33a-5p in pro-inflammatory EC can enhance ABCA1-dependent cholesterol efflux.
• To evaluate the efficacy of polymersome-mediated delivery of anti-miR-33a-5p to inflamed EC.
• To assess the atheroprotective potential of targeting miR-33a-5p in endothelial cells.

Main Methods:

• Transfection of LPS-challenged mouse aortic EC (iMAEC) with pAntimiR33a5p or control plasmid.
• Utilizing polymersomes for targeted delivery of anti-miR-33a-5p to inflamed iMAEC.
• Measuring ABCA1 protein expression and apoAI-mediated cholesterol efflux.

Main Results:

• Transfection with pAntimiR33a5p significantly increased ABCA1 protein and cholesterol efflux in iMAEC.
• Polymersomes selectively targeted pro-inflammatory iMAEC.
• Polymersome-delivered anti-miR-33a-5p significantly reduced miR-33a-5p expression in iMAEC.

Conclusions:

• Inhibition of miR-33a-5p in pro-inflammatory EC demonstrates atheroprotective effects.
• Targeted delivery of anti-miR-33a-5p via polymersomes is a viable anti-atherogenic strategy.
• This approach holds promise for preventing and treating atherosclerosis.